MAPT and Alzheimer disease: CSF Ng has also been correlated with many aspects of AD pathology, both with known biochemical changes in CSF t-tau and Aβ42 levels, as well as with tissue abnormalities such as the deposition of tau neurofibrillary deposits and β-amyloid plaques [121].